California Supreme Court Will Review Novel Negligence Theory for Pharmaceutical Manufacturers

The Situation: The California Supreme Court recently granted review of a California Court of Appeal decision, Gilead Life Sciences, Inc. v. The Superior Court of the City and County of San Francisco, that made waves in the pharmaceutical industry. The plaintiffs alleged that the pharmaceutical manufacturer Gilead acted negligently by postponing the development of a new HIV drug that was equally efficacious but had a lower risk of side effects than the existing Gilead drug….
By: Jones Day
Previous Story

Affiliated Dermatologists Notifies 380k Patients and Employees of March 2024 Data Breach

Next Story

Health Care, AI and Antitrust: Analysis and Next Steps